Some industry experts seem skeptical of the rumored deal between Amwell and Talkspace, while others disagree. The rumored purchasing price is $200 million at about $1.50 per share.
Humana has been rolling out a model for primary care centers designed to accommodate the growing number of senior citizens in the U.S. Staffed by integrated care teams, the centers offer a holistic approach that addresses both the medical and social needs of patients.
Tomorrow is your last chance to save $800 and gain exclusive networking access while hearing from industry experts who will discuss the opportunities and challenges the industry is facing.
INVEST 2023 will unite innovative startups, active investors as well as forward-thinking healthcare providers, payers and life science companies.
By Stephanie Baum Thursday, December 1, 2022 7:30 AM
In a webinar, flipMD and physicians discussed how the organization connects pioneering healthcare companies with expert physicians to maximize patient impact.
By Amanda James Wednesday, November 30, 2022 7:23 PM
Patient privacy is evolving rapidly in the post-Dobbs era, according to healthcare and life science lawyers in a webinar hosted by the American Bar Association on Wednesday.
By Katie Adams Wednesday, November 30, 2022 5:57 PM
Medical device manufacturer iCAD entered into a development and commercialization agreement with Google Health, in which it will integrate Google's mammography AI technology into its suite of breast imaging AI products. The agreement marks Google's first commercial partnership to deploy its breast imaging AI model into clinical practice.
By Katie Adams Wednesday, November 30, 2022 4:33 PM
Many of the efforts to address healthcare's burnout crisis have centered on money, such as hiring and retention bonuses, but that isn't sustainable. Providers don't have the means to keep throwing money at the problem forever, so they should focus more on creating a workplace culture where employees feel valued and supported.
By Arundhati Parmar Wednesday, November 30, 2022 2:33 PM
Miruna Sasu, CEO of RWE company COTA, explained that studies have shown meaningful improvements in efficiency if RWE is used in drug development and that translates into real savings. However, will such efforts continue amidst the ongoing belt-tightening in a tough economy?
By Laura Welke Wednesday, November 30, 2022 2:00 PM
While many will remember the Covid-19 pandemic as a source of disruption, it is likely that it will also be viewed as a catalyst for the transformation of medical education that had been brewing for the past decade.
By Frank Vinluan Wednesday, November 30, 2022 1:18 PM
Eisai has presented and published full data from the Phase 3 clinical trial for its Alzheimer's disease drug lecanemab, with results showing a statistically significant slowing decline associated with the neurodegenerative disorder. While an accelerated approval decision is expected in early 2023, the latest trial data are key because they represent the confirmatory study that could support an application for full FDA approval.
By Marissa Plescia Wednesday, November 30, 2022 12:46 PM
As the healthcare industry prepares for a possible recession, Ash Shehata of KPMG expects to see more use of technology, targeted investments and an impact on consumers' wallets.
By Shantanu Nundy Wednesday, November 30, 2022 9:00 AM
Covid-19 has forced us to face inequities present in health outcomes head-on and to recognize the systemic nature of health inequality that goes beyond the limits of what the healthcare system alone can change. The Quintuple Aim is a new framework for addressing these health inequities and centering our innovation and improvement efforts on marginalized communities and populations.
Among the takeaways from HLTH 2022 were the impact of consolidation on clinicians, behavioral health tools to help consumers manage stress and anxiety more productively, and how health tech and medtech companies are supporting remote patient monitoring and testing.
MedCity News 611 Broadway New York, NY 10012 United States
You received this email because you are subscribed to MedCity Daily Digest from MedCity News.
Update your email preferences to choose the types of emails you receive.
No comments